Ignite Creation Date:
2024-05-06 @ 1:02 PM
Last Modification Date:
2024-10-26 @ 1:07 PM
Study NCT ID:
NCT03913143
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-03-17
First Post:
2019-02-21
Brief Title:
A Study to Evaluate Efficacy Safety Tolerability and Exposure After a Repeat-dose of Sepofarsen QR-110 in LCA10 ILLUMINATE
Sponsor:
ProQR Therapeutics
Organization:
ProQR Therapeutics
Organization Data
Organization:
ProQR Therapeutics
Class:
INDUSTRY
Study ID:
PQ-110-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ProQR Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None